☆
Watchlist
Log in
Sign-up
Als Ltd (alq) Logo

Als Ltd (ALQ)

___:___ · Industrials
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials (10-yr)

ALQ Chart

Snapshot

ALQ's Principal Activity is the provision of professional technical services, primarily in the areas of testing, measurement and inspection supporting environmental monitoring, food and pharmaceutical quality assurance, mining and mineral exploration, commodity certification, equipment maintenance and asset care operations.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -13.83%
vs ASX 200 (1yr) -3.30%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 86 of 2,420
Sector Rank 11 of 187

Key Fundamentals

Shares Issued
Sector Industrials
Similar Companies CWY / QUB / SVW
EPS $0.364
DPS $0.304
Book Value Per Share $2.32

Broker Consensus

Breakdown 9 Buy · 4 Hold · 1 Sell
Recommendation Buy
Last Updated 04/06/22

Top Market Index News

More News

Announcements

Date Heading Pages File Size Time

Corporate Overview

ALS Limited (ALQ) provides professional technical services, primarily in the areas of testing, measurement and inspection, supporting: environmental monitoring; food and pharmaceutical quality assurance; mining and mineral exploration; commodity certification; equipment maintenance; and asset care operations.

Incorporation Details

Incorporated in Qld in December 1910 as Campbell Brothers Pty Ltd, converted to a public company as Campbell Brothers Ltd on 07/04/1952.

Corporate Details

Head Office Milton QLD 4064
Website www.alsglobal.com
Registry BoardRoom
Auditor Ernst & Young
Date Listed 24 Aug 1971

Upcoming Calendar (Forecasted)

Date Event
04/07/2022 Div Pay Date
16/11/2022 Report (Interim)
24/05/2023 Report (Prelim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
06/06/2022 $0.17 30% $0.1919 Final 04/07/2022
02/12/2021 $0.158 30% $0.1783 Interim 17/12/2021
07/06/2021 $0.146 70% $0.1898 Final 05/07/2021
26/11/2020 $0.085 100% $0.1214 Interim 16/12/2020
05/06/2020 $0.061 70% $0.0793 Final 06/07/2020
27/11/2019 $0.115 30% $0.1298 Interim 16/12/2019
03/06/2019 $0.115 35% $0.1323 Final 01/07/2019
29/11/2018 $0.11 20% $0.1194 Interim 18/12/2018
06/06/2018 $0.09 40% $0.1054 Final 02/07/2018
29/11/2017 $0.08 40% $0.0937 Interim 18/12/2017
07/06/2017 $0.08 40% $0.0937 Final 03/07/2017
05/12/2016 $0.055 60% $0.0691 Interim 21/12/2016
08/06/2016 $0.06 40% $0.0703 Final 01/07/2016
03/12/2015 $0.075 25% $0.083 Interim 18/12/2015
09/06/2015 $0.10 25% $0.1107 Final 01/07/2015
02/12/2014 $0.11 10% $0.1147 Interim 19/12/2014
11/06/2014 $0.20 50% $0.2429 Final 02/07/2014
29/11/2013 $0.19 50% $0.2307 Interim 20/12/2013
07/06/2013 $0.27 50% $0.3279 Final 02/07/2013
29/11/2012 $0.21 50% $0.255 Interim 18/12/2012
04/06/2012 $1.30 50% $1.5786 Final 02/07/2012
Show All

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM) $0.304
Gross DPS(TTM) $0.3681
Dividend yield
Gross yield
Payout Ratio 84%
DRP Yes
DRP Features 0%

Directors & Management

Directors & Management

Name Title Since Bio
Ms Leslie A Desjardins Non-Executive Director Nov 2019

Ms Leslie A Desjardins

Non-Executive Director

Ms Desjardins has a background as a CFO and senior financial and governance professional in a range of large multinational and global businesses. She has commercial and financial governance expertise with large multinational public companies in North America, Canada and Australia each with extensive global operations. Her areas of expertise include CFO level executive and financial strategic leadership, M&A, corporate finance and treasury, governance, financial and tax compliance and enterprise risk management. Ms Desjardins is currently a Director, Audit Committee Chair, CSR/Risk Committee member with Ansell Limited and Director and Audit Committee Chair with Terry Fox Foundation, Canada. Previously, she served as a Board Director and Audit Committee member with AptarGroup. During her executive career, Ms Desjardins served as Executive VP and CFO at Amcor Limited, a global leader in packaging of food, beverage, pharmaceutical and tobacco products. Prior to Amcor Ltd, Ms Desjardins served in financial and corporate strategic positions with General Motors Corporation, including Chief Financial Officer GM Holden Australia, Controller GM North America, Executive Director Manufacturing Finance and Director GM North America Strategy and Planning. Ms Desjardins holds a Master of Science, Business with Massachusetts Institute of Technology, Sloan and a Bachelor of Industrial Administration, Finance with Kettering University. She is the Chair of the Risk Committee.

Dr Siddhartha Kadia Non-Executive Director Jan 2019

Dr Siddhartha Kadia

Non-Executive Director

Dr Kadia was formerly President and CEO of EAG Laboratories, a global scientific testing company headquartered in San Diego. He has also been a Director of USA-listed companies Newport Corporation (NSDQ: NEWP) and Volcano Corporation (NSDQ: VOLC). He is currently a Non-Executive Director of BioSkryb Inc, Nuvasive, Inc (appointed February 2021) and other US-based companies including Isoplexis, ATS (Applied Technical Services), Overseers. Prior to EAG, Siddhartha served as President of the Life Sciences Division at Life Technologies Corporation (NSDQ: LIFE), a publicly traded Life Sciences tools company. Siddhartha was also a management consultant at McKinsey & Company where his work focused on various life sciences and healthcare related engagements. Siddhartha has lived and worked in the US, Japan, China and India and has more than 20 years of international experience as a company director, executive and technical leader in the Life Sciences and TIC (testing, inspection and certification) sectors. He is a member of the Sustainability and Innovation Committee and the People Committee.

Mr Michael Paul Pearson Company Secretary Dec 2017
Mr Raj Naran Chief Executive Officer,Managing Director Feb 2017

Mr Raj Naran

Chief Executive Officer,Managing Director

Mr Naran founded e-Lab Analytical Inc which operated an environmental analytical testing business in Texas and Michigan until it was acquired by the Group in 2007. He was appointed to lead ALS USA Environmental business at that time and grew his role over the subsequent years to lead the global Life Sciences Division until his appointment to CEO in 2017. In December 2018 Raj was appointed as a Non-Executive Director to Redeye Apps Limited.

Ms Tonianne Dwyer Non-Executive Director Jul 2016

Ms Tonianne Dwyer

Non-Executive Director

Ms Dwyer has experience as a company director and executive working in finance, corporate strategy and mergers and acquisitions across a variety of sectors and international markets. She is an internationally experienced independent company director, having had a 25-year executive career in investment banking during which she held roles with Hambros Bank Limited and Societe General in the UK and Europe. She is Deputy Chancellor of the Senate of the University of Queensland and is on the Board of the Sir John Monash Foundation and Chief Executive Women. She is Chair of the People Committee and a member of the Sustainability and Innovation Committee.

Mr Bruce John Phillips Non-Executive Director,Non-Executive Chairman Aug 2015

Mr Bruce John Phillips

Non-Executive Director,Non-Executive Chairman

Mr Phillips have more than 35 years of technical, financial and managerial experience in the energy sector. He was previously Chairman of Platinum Capital Limited (October 2009 - June 2015) and a Non-Executive Director of AGL Energy Limited (August 2007 - September 2016) and Sunshine Gas Limited. In January 2019 Bruce was appointed as a Non-Executive Director and Chairman of Karoon Energy Limited. He is a member of the People Committee.

Mr Charlie Sartain Non-Executive Director Feb 2015

Mr Charlie Sartain

Non-Executive Director

Mr Sartain spent more than 30 years with MIM Holdings and then Xstrata plc after it acquired MIM. He led Xstrata's global copper business as Chief Executive of Xstrata Copper for nine years from 2004 and prior to that held senior executive positions with the company in Latin America and Australia. Charlie is currently a Non-Executive Director of OZ Minerals Limited, Chairman of the Advisory Board of the Sustainable Minerals Institute at the University of Queensland, and Chairman of the Board of Wesley Medical Research Ltd. His previous roles included Chairman of the International Copper Association, a Member of the Department of Foreign Affairs and Trade's Council on Australian Latin American Relations and a Director of Xstrata Schweiz Limited. He also served as a Non-Executive Director of Austin Engineering Limited, Goldcorp Inc., Newmont Corporation and as a two-term Member of the Senate of the University of Queensland. He was awarded an Honorary Doctorate in Engineering by the University of Queensland in 2019. He is Chairman of the Sustainability and Innovation Committee and Risk Committee.

Dr John Francis Mulcahy Non-Executive Director Feb 2012

Dr John Francis Mulcahy

Non-Executive Director

Dr Mulcahy is Chairman of Mirvac Group Limited (appointed November 2009 and Chair September 2013) and Orix Australia Corporation Limited, an unlisted public company (appointed March 2016), and Deputy Chairman of GWA Group Limited (appointed November 2010). He is also a current Non-Executive Director of various Zurich Australia Insurance subsidiaries. John was previously a director and Chairman of Coffey International Limited (September 2009 - January 2016). He is a former Guardian of the Future Fund of Australia and former Managing Director and Chief Executive Officer of Suncorp-Metway Limited. Prior to Suncorp, John held a number of senior executive roles at the Commonwealth Bank and Lend Lease Corporation. He is a member of the People Committee and Risk Committee.

Luis Damasceno Chief Financial Officer N/A
Bruce McDonald GM Geochemistry N/A
Kristen Walsh GM Industrial N/A
Tim Kilmister GM Life Sciences APAC N/A
Andreas Jonsson GM Life Sciences EMEA N/A

Director Transactions

ALQ directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
31/05/22 Leslie Desjardins Buy +6,800 $12.91 $87,788 On-market trade
13/01/22 Raj Naran Sell +30,000 $12.864 ($385,932) As advised by the company
01/09/21 Raj Naran Sell +79,500 $12.373 ($983,647) As advised by the company
02/08/21 Siddhartha Kadia Buy +9,380 $12.47 $116,968 On-market trade
28/07/21 Raj Naran Issued 112,436 $12.403 $1,394,544 Issue of securities
01/07/21 Raj Naran Buy +131,582 $12.86 $1,692,144 Conversion of securities
01/07/21 Raj Naran Exercise 131,582 $12.86 $1,692,144 Conversion of securities
01/07/21 Raj Naran Cancelled 2,801 $12.86 $36,020 Cancellation of securities
01/07/20 Raj Naran Buy +87,289 $6.67 $582,217 Conversion of securities
01/07/20 Raj Naran Expiry 29,721 $6.67 $198,239 As advised by the company
01/07/20 Raj Naran Exercise 87,289 $6.67 $582,217 Conversion of securities
01/07/20 Raj Naran Issued 154,017 $7.06 $1,087,358 Issue of securities
11/06/20 Leslie Desjardins Buy +7,300 $7.37 $53,801 On-market trade
10/07/19 Raj Naran Buy +14,983 $7.54 $112,972 On-market trade
02/07/19 Raj Naran Exercise 44,948 $7.70 $346,100 Conversion of securities
02/07/19 Raj Naran Expiry 7,500 $7.70 $57,750 As advised by the company
02/07/19 Raj Naran Buy +44,948 $7.70 $346,100 Conversion of securities

Director Interests

The current holdings of ALQ directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Leslie Desjardins 31/05/2022 14,100 N/A N/A N/A
Raj Naran 13/01/2022 244,680 15,000 N/A N/A
Siddhartha Kadia 02/08/2021 0 9,380 N/A N/A
Tonianne Dwyer 31/03/2021 N/A 27,148 N/A N/A
Charlie Sartain 31/03/2021 N/A 90,000 N/A N/A
John Mulcahy 31/03/2021 N/A 54,027 N/A N/A
Bruce Phillips 31/03/2021 N/A 60,160 N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Jun 2, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
HSBC Custody Nominees (Australia) Limited 125,867,258 26.09%
J P Morgan Nominees Australia Pty Limited 70,284,084 14.57%
Citicorp Nominees Pty Limited 47,739,469 9.90%
BNP Paribas Noms Pty Ltd <Drp> 22,979,364 4.76%
National Nominees Limited 20,223,337 4.19%
Citicorp Nominees Pty Limited <Colonial First State Inv A/C> 16,753,107 3.47%
BNP Paribas Nominees Pty Ltd <Agency Lending Drp A/C> 10,053,016 2.08%
Faircase Pty Ltd 7,803,731 1.62%
Australian Foundation Investment Company Limited 7,012,164 1.45%
Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> 6,808,331 1.41%
Milton Corporation Limited 6,079,431 1.26%
Argo Investments Limited 5,104,023 1.06%
HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 4,675,865 0.97%
CS Third Nominees Pty Limited <Hsbc Cust Nom Au Ltd 13 A/C> 2,885,532 0.60%
BNP Paribas Nominees Pty Ltd Six Sis Ltd <Drp A/C> 1,954,777 0.40%
Netwealth Investments Limited <Wrap Services A/C> 1,504,207 0.31%
Brispot Nominees Pty Ltd <House Head Nominee A/C> 1,444,389 0.30%
Ms Maryon Catherine Campbell <The Checkmate A/C> 1,372,574 0.29%
Avanteos Investments Limited <Encircle Ima A/C> 1,260,612 0.26%
EST Mrs Joyce Selina Hinds 1,193,227 0.25%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

No Substantial Shareholders for ALQ in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
15-12-21 First Sentier Investors Holdings Pty Limited 24,182,246 -- 5.01
15-12-21 Mitsubishi UFJ Financial Group, Inc. 24,182,246 -- 5.01
03-12-21 Commonwealth Bank of Australia and its related bodies corporate 4,952,270 5.01 6.03
01-12-21 Comet Asia Holdings II Pte Ltd 28,056,085 -- 5.82
01-12-21 Superannuation and Investments HoldCo Pty Ltd 28,056,085 -- 5.82
19-11-21 First Sentier Investors Holdings Pty Limited 24,245,665 -- 5.03
19-11-21 Mitsubishi UFJ Financial Group, Inc. 24,241,703 -- 5.02

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
12-05-22 Commonwealth Bank of Australia and its related bodies corporate 29,101,055 6.03 --
11-05-22 Superannuation and Investments HoldCo Pty Ltd 28,056,085 5.82 --
11-05-22 Comet Asia Holdings II Pte Ltd 28,056,085 5.82 --
18-02-22 Mitsubishi UFJ Financial Group, Inc. 24,182,246 5.01 --
18-02-22 First Sentier Investors Holdings Pty Limited 24,182,246 5.01 --
02-12-21 Mitsubishi UFJ Financial Group, Inc. 24,241,703 5.02 --
02-12-21 First Sentier Investors Holdings Pty Limited 24,245,665 5.03 --
05-11-21 The Vanguard Group Inc. 24,502,238 5.03 --

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2021 $13.04 30 June
2020 $6.56 30 June
2019 $7.34 28 June
2018 $7.54 29 June
2017 $7.45 28 June
2016 $4.89 28 June
2015 $5.85 30 June
2014 $8.86 30 June
ALQ Historical Price Data (CSV)
Up to 20 years of EOD share price history
Sign up to Download
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.